Sequenom Pushes Fed. Circ. To Bar Ariosa Prenatal Test
By Erica Teichert ( January 9, 2013, 4:27 PM EST) -- Sequenom Inc. urged a Federal Circuit panel on Wednesday to bar its competitor Ariosa Diagnostics Inc. from selling a noninvasive prenatal blood test even though the order could jeopardize Ariosa's existence, saying the prospect of catastrophic harm to a company's business shouldn't be a "get out of jail free" card for patent infringement....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.